Achieve Life Sciences ACHV Stock
2.18 USD
{{ price }}
-9.917356%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
75.61M USD
LOW - HIGH [24H]
2.12
-
2.45 USD
VOLUME [24H]
580.07K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.24 USD
Achieve Life Sciences Price Chart
Achieve Life Sciences ACHV Financial and Trading Overview
| Achieve Life Sciences stock price | 2.18 USD |
| Previous Close | 6.3 USD |
| Open | 6.17 USD |
| Bid | 0 USD x 1400 |
| Ask | 0 USD x 1200 |
| Day's Range | 5.88 - 6.24 USD |
| 52 Week Range | 2 - 10.3 USD |
| Volume | 172.32K USD |
| Avg. Volume | 188.65K USD |
| Market Cap | 124.14M USD |
| Beta (5Y Monthly) | 1.562676 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.24 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 28.57 USD |
ACHV Valuation Measures
| Enterprise Value | 113.63M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.4911242 |
| PEG Ratio (5 yr expected) | -0.23 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 236 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.711 |
Trading Information
Achieve Life Sciences Stock Price History
| Beta (5Y Monthly) | 1.562676 |
| 52-Week Change | 5.16% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 10.3 USD |
| 52 Week Low | 2 USD |
| 50-Day Moving Average | 7.29 USD |
| 200-Day Moving Average | 4.66 USD |
ACHV Share Statistics
| Avg. Volume (3 month) | 188.65K USD |
| Avg. Daily Volume (10-Days) | 124.71K USD |
| Shares Outstanding | 21.04M |
| Float | 17.86M |
| Short Ratio | 3.07 |
| % Held by Insiders | 8.50% |
| % Held by Institutions | 33.13% |
| Shares Short | 798.31K |
| Short % of Float | 4.56% |
| Short % of Shares Outstanding | 3.79% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -85.79% |
| Return on Equity (ttm) | -400.15% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -41918000 USD |
| Net Income Avi to Common (ttm) | -43769000 USD |
| Diluted EPS (ttm) | -3.9 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.51M USD |
| Total Cash Per Share (mrq) | 0.92 USD |
| Total Debt (mrq) | 16.48M USD |
| Total Debt/Equity (mrq) | 3720.77 USD |
| Current Ratio (mrq) | 0.898 |
| Book Value Per Share (mrq) | 0.025 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -39073000 USD |
| Levered Free Cash Flow (ttm) | -24266124 USD |
Profile of Achieve Life Sciences
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 1040 West Georgia Street |
| ZIP | V6E 4H1 |
| Phone | (604) 210-2217 |
| Website | https://www.achievelifesciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 20 |
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.
Q&A For Achieve Life Sciences Stock
What is a current ACHV stock price?
Achieve Life Sciences ACHV stock price today per share is 2.18 USD.
How to purchase Achieve Life Sciences stock?
You can buy ACHV shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Achieve Life Sciences?
The stock symbol or ticker of Achieve Life Sciences is ACHV.
Which industry does the Achieve Life Sciences company belong to?
The Achieve Life Sciences industry is Biotechnology.
How many shares does Achieve Life Sciences have in circulation?
The max supply of Achieve Life Sciences shares is 34.69M.
What is Achieve Life Sciences Price to Earnings Ratio (PE Ratio)?
Achieve Life Sciences PE Ratio is now.
What was Achieve Life Sciences earnings per share over the trailing 12 months (TTM)?
Achieve Life Sciences EPS is -1.24 USD over the trailing 12 months.
Which sector does the Achieve Life Sciences company belong to?
The Achieve Life Sciences sector is Healthcare.
Achieve Life Sciences ACHV included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15587.79 USD — |
-5.82
|
9.14B USD — | 15575.68 USD — | 16128.16 USD — | — - | 9.14B USD — |
| NASDAQ Capital Market Composite RCMP | 92.16 USD — |
-4.45
|
— — | 89.57 USD — | 93.85 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 869.8 USD — |
-5.51
|
— — | 868.74 USD — | 900.72 USD — | — - | — — |
- {{ link.label }} {{link}}